Wan-Jin Chen: Clinical Trials

5 trials sponsored by Wan-Jin Chen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Wan-Jin Chen: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke
Methylprednisolone sodium succinate, Placebo - Acute Ischemic Stroke, Large Infarct Core
Phase 3Active not recruitingWan-Jin Chen9282024-08-012025-12-03
A Registered Cohort Study on Brain Calcification
Brain Calcification
RecruitingWan-Jin Chen20002019-08-252019-09-23
A Registered Cohort Study on Wilson's Disease
No intervention - Wilson's Disease
RecruitingWan-Jin Chen20002019-07-012019-09-23
A Registered Cohort Study on SMA
Spinal Muscular Atrophy
RecruitingWan-Jin Chen20002019-07-012019-09-23
A Registered Cohort Study on Spastic Paraplegia
Spastic Paraplegia
RecruitingWan-Jin Chen5002019-07-012022-01-19

Conditions studied

Hepatolenticular Degeneration (1)  ·  Ischemic Stroke (1)  ·  Muscular Atrophy, Spinal (1)  ·  Paraplegia (1)

Interventions

Methylprednisolone Hemisuccinate (1)

Countries

China (5)

Results publications

PMID 34538260, PMID 35017251, PMID 38651515, PMID 39853345